The objective of the trial was to evaluate the efficacy of the association of topotecan and lapatinib in patients who failed first line platinum-based chemotherapy within 12 months.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
39
Centre François Baclesse
Caen, CALVADOS, France
Centre Paul Papin
Angers, France
Evaluation of global response rate (complete response, partial response and stable disease)of the association topotecan-lapatinib.
Time frame: every two cycles of chemotherapy
Global survival rate, survival rate without progression, response time, time without progression, safety, quality of life, Caracterisation of biological response (tumor, ascite and blood samples)
Time frame: each cycle of chemotherapy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
CHU Jean MINJOZ
Besançon, France
Institut Bergonié
Bordeaux, France
Centre G-F Leclerc
Dijon, France
CHD Les Oudairies
La Roche-sur-Yon, France
Centre Jean Bernard
Le Mans, France
Centre Val d'Aurelle
Montpellier, France
Centre azuréen de cancérologie
Mougins, France
Centre Alexis vautrin
Nancy, France
...and 11 more locations